Browse Studies — Arctuva

Phase 1

A Phase 1, First-in-Human, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FX-111 in Patients With Metastatic Castration-Resistant Prostate Cancer

The goal of this clinical trial is to find out if FX-111 is safe enough to permit further studies in adult male participants with metastatic castration-resista…

Metastatic Castration Resistant Prostate CancermCRPCmCRPC (Metastatic Castration-resistant Prostate Cancer)+6 more

Estimated

~$10 – $8,750

Flare Therapeutics Inc.NCT07719361

Office Based MRI/Ultrasound Guided Prostate Cryotherapy: Outcomes Registry

Registration of Prostate Cancer patients undergoing Prostate Cryotherapy guided by Mutiparametric-MRI (MP-MRI) highlighting biopsy confirmed regions. The prima…

Neoplasms ProstateCancer of the Prostate

Estimated

~$10 – $1,050

Urological Research Network, LLCNCT02381990

Office Based MRI/Ultrasound Guided Prostate Cancer Ablation: Outcomes Registry

This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy c…

Neoplasms ProstateCancer of the Prostate

Estimated

~$10 – $1,050

Urological Research Network, LLCNCT05241236